IDHC — Integrated Diagnostics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $312.46m
- $319.11m
- EGP5.72bn
- 98
- 52
- 90
- 96
Annual cashflow statement for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 969 | 2,232 | 854 | 737 | 1,440 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 54.7 | 54.8 | 3.12 | 61.3 | -169 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -327 | -256 | -965 | -656 | -185 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 883 | 2,270 | 209 | 544 | 1,569 |
| Capital Expenditures | -126 | -264 | -309 | -326 | -225 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.74 | -1,064 | 1,299 | 82 | -222 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -124 | -1,328 | 990 | -244 | -447 |
| Financing Cash Flow Items | -56.4 | -114 | -123 | -86 | -312 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -564 | -647 | -1,618 | -330 | -749 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 191 | 291 | -243 | 25.7 | 514 |